--------------------
human
65–85
hemoconcentration
Cannulation
REF].Thrombosed
Thrombus
Thrombosed
--------------------
create
AVGs
AVFs
AVGs
AVFs
--------------------
explain
AVGs
AVFs
--------------------
continue
AVGs
AVFs
Thrombectomy
rheolytic
--------------------
human
disease-2019
78%.5
CSDH)8
--------------------
explain
--------------------
create
Disease-2019
disease-2019
--------------------
continue
disease-2019
--------------------
human
immunoregulation
eATP
eATP
eATP
purinoceptor
eATP
eADO
ectonucleotidases
REF].eADO
signaling.eADO
eATP
ectonucleotidases
eATP
CD39
ectonucleoside
diphosphohydrolase
eADO
CD73
5′-nucleotidase
eAMP
eADO
eAMP
eATP
NDPK
REF].The
eADO
ectohydrolase
CD203a
ectonucleotide
ADPR
--------------------
continue
adenosinergic
eADO
eADO
eADO
ectonucleotidases
CD39
CD73
eATP
eADO
eADO
adenosinergic
eADO
adenosinergic
ectonucleotidases
CD39
CD73
adenosinergic
adenosinergic
adenosinergic
--------------------
explain
immunoregulation
eATP
eATP
purinoceptor
eATP
eADO
ectonucleotidases
eADO
eATP
CD39
CD73
CD203a
eADO
CD73
eADO
--------------------
create
adenosinergic
eADO
eATP
eATP
eADO
eATP
eADO
adenosinergic
adenosinergic
adenosinergic
adenosinergic
eATP
eADO
--------------------
human
REF]).Detailed
sarcopenic
--------------------
create
Jentoft
Beaudart
AgeiNg
ENHANce
ENHANce
sarcopenic
--------------------
explain
sarcopenic
sarcopenic
--------------------
continue
ENHANce
ENHANce
sarcopenic
SarQoL
--------------------
continue
hyperinflammatory
--------------------
human
PASC.The
https://recovercovid.org/protocols
PASC.The
--------------------
create
--------------------
explain
